Ligand Pharmaceuticals Inc, Ten Percent Owner at Viking Therapeutics, holds 1.50M shares in Pelthos Therapeutics (Ticker: PTHS), holds 0.00 shares in OmniAb, Inc. (Ticker: OABIV), holds 5.82M shares in Viking Therapeutics (Ticker: VKTX). Most recently, Ligand Pharmaceuticals Inc Bought ― shares of Pelthos Therapeutics on Jul 03, 2025 for an estimated value of $15.00M.
What was Ligand Pharmaceuticals Inc’s latest transaction?
Ligand Pharmaceuticals Inc latest transaction was an Informative Buy of $15.00M.
What was Ligand Pharmaceuticals Inc's most profitable transaction?
Ligand Pharmaceuticals Inc’s most profitable transaction was an Informative Buy of PTHS stock on July 3, 2025. The return on the trade was 74.30%.
What is Ligand Pharmaceuticals Inc's role in Viking Therapeutics?
Ligand Pharmaceuticals Inc's role in Viking Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.